Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 68

Sort by

Sort Order Select

Journal Articles

Canonical Wnt: a safeguard and threat for erythropoiesis

Rosa A. Krimpenfort, Micha Nethe

Blood Adv (2021) 5 (18): 3726–3735.

https://doi.org/10.1182/bloodadvances.2021004845

Published: 2021

Journal Articles

DKK1 activates noncanonical NF-κB signaling via IL-6–induced CKAP4 receptor in multiple myeloma

Xin Li, Jingjing Wang, Shuai Zhu, Jinxin Zheng, Ying Xie, Hongmei Jiang, Jing Guo, Yixuan Wang, Ziyi Peng, Mengqi Wang, Jingya Wang, Sheng Wang, Yuping Zhong, Zhiqiang Liu

Blood Adv (2021) 5 (18): 3656–3667.

https://doi.org/10.1182/bloodadvances.2021004315

Published: 2021

Includes: Supplemental data

Journal Articles

Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance

Justin Anthony Chen, Yanli Hou, Krishna M. Roskin, Daniel A. Arber, Charles D. Bangs, Linda B. Baughn, Athena M. Cherry, Mark D. Ewalt, Andrew Z. Fire, Laure Fresard, Hutton M. Kearney, Stephen B. Montgomery, Robert S. Ohgami, Kathryn E. Pearce, Beth A. Pitel, Jason D. Merker, Jason Gotlib

Blood Adv (2021) 5 (17): 3492–3496.

https://doi.org/10.1182/bloodadvances.2020004174

Published: 2021

Includes: Supplemental data

Journal Articles

Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease

Blood Adv (2021) 5 (17): 3445–3456.

https://doi.org/10.1182/bloodadvances.2020004016

Published: 2021

Includes: Supplemental data

Journal Articles

RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia

Stavroula Ntoufa, Marina Gerousi, Stamatia Laidou, Fotis Psomopoulos, Georgios Tsiolas, Theodoros Moysiadis, Nikos Papakonstantinou, Larry Mansouri, Achilles Anagnostopoulos, Niki Stavrogianni, Sarka Pospisilova, Karla Plevova, Antonios M. Makris, Richard Rosenquist, Kostas Stamatopoulos

Blood Adv (2021) 5 (13): 2788–2792.

https://doi.org/10.1182/bloodadvances.2020001717

Published: 2021

Includes: Supplemental data

Journal Articles

G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death

Eva De Smedt, Julie Devin, Catharina Muylaert, Nicolas Robert, Guilhem Requirand, Philip Vlummens, Laure Vincent, Guillaume Cartron, Ken Maes, Jerome Moreaux, Elke De Bruyne

Blood Adv (2021) 5 (9): 2325–2338.

https://doi.org/10.1182/bloodadvances.2020003217

Published: 2021

Includes: Supplemental data

Journal Articles

Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR -mutated MPNs

Manjola Balliu, Laura Calabresi, Niccolò Bartalucci, Simone Romagnoli, Laura Maggi, Rossella Manfredini, Matteo Lulli, Paola Guglielmelli, Alessandro Maria Vannucchi

Blood Adv (2021) 5 (8): 2184–2195.

https://doi.org/10.1182/bloodadvances.2020003291

Published: 2021

Includes: Supplemental data

Journal Articles

Tetherin/BST2, a physiologically and therapeutically relevant regulator of platelet receptor signalling

Xiaojuan Zhao, Dominic Alibhai, Ting Sun, Jawad Khalil, James L. Hutchinson, Kaya Olzak, Christopher M. Williams, Yong Li, Richard Sessions, Stephen Cross, Richard Seager, Riyaad Aungraheeta, Alan Leard, Caroline M. McKinnon, David Phillips, Lei Zhang, Alastair W. Poole, George Banting, Stuart J. Mundell

Blood Adv (2021) 5 (7): 1884–1898.

https://doi.org/10.1182/bloodadvances.2020003182

Published: 2021

Includes: Supplemental data

Journal Articles

Disruption of CSF-1R signaling inhibits growth of AML with inv(16)

Alexander Simonis, Norman F. Russkamp, Jan Mueller, C. Matthias Wilk, Mattheus H. E. Wildschut, Renier Myburgh, Nicole Wildner-Verhey van Wijk, Rouven Mueller, Stefan Balabanov, Peter J. M. Valk, Alexandre P. A. Theocharides, Markus G. Manz

Blood Adv (2021) 5 (5): 1273–1277.

https://doi.org/10.1182/bloodadvances.2020003125

Published: 2021

Includes: Supplemental data

Journal Articles

JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells

Blood Adv (2021) 5 (3): 889–899.

https://doi.org/10.1182/bloodadvances.2020002702

Published: 2021

Includes: Supplemental data

Journal Articles

JAK2 S523L, a novel gain-of-function mutation in a critical autoregulatory residue in JAK2 V617F − MPNs

Friederike Pastore, Aishwarya Krishnan, Henrik M. Hammarén, Olli Silvennoinen, Benedict Yan, Ross L. Levine

Blood Adv (2020) 4 (18): 4554–4559.

https://doi.org/10.1182/bloodadvances.2019001283

Published: 2020

Includes: Supplemental data

Journal Articles

Cysteine sulfenylation by CD36 signaling promotes arterial thrombosis in dyslipidemia

Moua Yang, Wei Li, Calvin Harberg, Wenjing Chen, Hong Yue, Renan B. Ferreira, Sarah L. Wynia-Smith, Kate S. Carroll, Jacek Zielonka, Robert Flaumenhaft, Roy L. Silverstein, Brian C. Smith

Blood Adv (2020) 4 (18): 4494–4507.

https://doi.org/10.1182/bloodadvances.2020001609

Published: 2020

Includes: Multimedia, Supplemental data

Journal Articles

Targeting phosphatidylinositol 3 kinase-β and -δ for Bruton tyrosine kinase resistance in diffuse large B-cell lymphoma

Blood Adv (2020) 4 (18): 4382–4392.

https://doi.org/10.1182/bloodadvances.2020001685

Published: 2020

Includes: Supplemental data

Journal Articles

CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia

Anthony Quagliano, Anilkumar Gopalakrishnapillai, E. Anders Kolb, Sonali P. Barwe

Blood Adv (2020) 4 (18): 4393–4405.

https://doi.org/10.1182/bloodadvances.2020001592

Published: 2020

Includes: Supplemental data

Journal Articles

AKT signaling restrains tumor suppressive functions of FOXO transcription factors and GSK3 kinase in multiple myeloma

Timon A. Bloedjes, Guus de Wilde, Chiel Maas, Eric Eldering, Richard J. Bende, Carel J. M. van Noesel, Steven T. Pals, Marcel Spaargaren, Jeroen E. J. Guikema

Blood Adv (2020) 4 (17): 4151–4164.

https://doi.org/10.1182/bloodadvances.2019001393

Published: 2020

Includes: Supplemental data

Journal Articles

Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD

Eleonora Latis, David Michonneau, Claire Leloup, Hugo Varet, Régis Peffault de Latour, CRYOSTEM Consortium, Elisabetta Bianchi, Gérard Socié, Lars Rogge

Blood Adv (2020) 4 (16): 3927–3942.

https://doi.org/10.1182/bloodadvances.2019001032

Published: 2020

Includes: Supplemental data

Journal Articles

Neutrophils lacking ERM proteins polarize and crawl directionally but have decreased adhesion strength

Sumith R. Panicker, Tadayuki Yago, Bojing Shao, Rodger P. McEver

Blood Adv (2020) 4 (15): 3559–3571.

https://doi.org/10.1182/bloodadvances.2020002423

Published: 2020

Includes: Multimedia, Supplemental data

Journal Articles

Inflammation-driven activation of JAK/STAT signaling reversibly accelerates acute myeloid leukemia in vitro

Jan Habbel, Lucas Arnold, Yiyang Chen, Michael Möllmann, Kirsten Bruderek, Sven Brandau, Ulrich Dührsen, Maher Hanoun

Blood Adv (2020) 4 (13): 3000–3010.

https://doi.org/10.1182/bloodadvances.2019001292

Published: 2020

Includes: Supplemental data

Journal Articles

Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome

Je-Hwan Lee, Stefan Faderl, John M. Pagel, Chul Won Jung, Sung-Soo Yoon, Animesh D. Pardanani, Pamela S. Becker, Howard Lee, Jeongeun Choi, Kyoungjune Lee, Minkyoung Kim, Jorge E. Cortes

Blood Adv (2020) 4 (9): 2032–2043.

https://doi.org/10.1182/bloodadvances.2019000757

Published: 2020

Includes: Supplemental data

Journal Articles

Huang L, Sun X, Yang D, et al. WASP and Mst1 coregulate B-cell development and B-cell receptor signaling. Blood Adv. 2020;4(3):573-585.

Blood Adv (2020) 4 (9): 1916.

https://doi.org/10.1182/bloodadvances.2020002133

Published: 2020

NARROW

Canonical Wnt: a safeguard and threat for erythropoiesis

DKK1 activates noncanonical NF-κB signaling via IL-6–induced CKAP4 receptor in multiple myeloma

Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance

Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease

RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia

G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death

Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR -mutated MPNs

Tetherin/BST2, a physiologically and therapeutically relevant regulator of platelet receptor signalling

Disruption of CSF-1R signaling inhibits growth of AML with inv(16)

JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells

JAK2 S523L, a novel gain-of-function mutation in a critical autoregulatory residue in JAK2 V617F − MPNs

Cysteine sulfenylation by CD36 signaling promotes arterial thrombosis in dyslipidemia

Targeting phosphatidylinositol 3 kinase-β and -δ for Bruton tyrosine kinase resistance in diffuse large B-cell lymphoma

CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia

AKT signaling restrains tumor suppressive functions of FOXO transcription factors and GSK3 kinase in multiple myeloma

Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD

Neutrophils lacking ERM proteins polarize and crawl directionally but have decreased adhesion strength

Inflammation-driven activation of JAK/STAT signaling reversibly accelerates acute myeloid leukemia in vitro

Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome

Huang L, Sun X, Yang D, et al. WASP and Mst1 coregulate B-cell development and B-cell receptor signaling. Blood Adv. 2020;4(3):573-585.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only